New migraine prevention guidelines reflect expanding treatment options

New clinical guidelines for migraine prevention were released, reflecting a growing array of therapeutic options. The update signals a shift in standard care but does not introduce a specific new drug or trial result. This matters for patients and providers as it codifies broader treatment choices, though no market-moving data is included.